The patient or his/her representative must have given free and informed consent and signed the consent
The patient must be insured or beneficiary of a health insurance plan
The patient is available for 12 months of follow-up
The patient underwent a successful transcutaneous implant procedure for an aortic valve within the past 24 hours
The patient was receiving anti-vitamin K (AVK) treatment before percutaneous implantation of the aortic valve

NCT02735902_inc_T4
Procedure
transcutaneous implant procedure
NCT02735902_inc_T5
Device
aortic valve
NCT02735902_inc_T6
Temporal
past 24 hours
NCT02735902_inc_T7
Drug
anti-vitamin K
NCT02735902_inc_T8
Drug
AVK
NCT02735902_inc_T9
Temporal
before percutaneous implantation of the aortic valve
NCT02735902_inc_T10
Reference_point
percutaneous implantation of the aortic valve